$AORT
ARTIVION, INC.

2020 Q4 Form 10-Q Financial Statement

#000078419920000208 Filed on November 05, 2020

View on sec.gov

Income Statement

Concept 2020 Q4 2020 Q3 2019 Q3
Revenue $67.90M $65.13M $67.88M
YoY Change -2.58% -4.05% 5.08%
Cost Of Revenue $23.31M $22.00M $22.66M
YoY Change -2.91% 3.54%
Gross Profit $44.59M $43.13M $45.22M
YoY Change -4.21% -4.62% 5.87%
Gross Profit Margin 65.68% 66.22% 66.62%
Selling, General & Admin $26.97M $33.74M $34.26M
YoY Change -1.51% 4.22%
% of Gross Profit 60.48% 78.23% 75.76%
Research & Development $5.755M $6.259M
YoY Change -8.05% 19.79%
% of Gross Profit 13.34% 13.84%
Depreciation & Amortization $5.894M $14.82M
YoY Change
% of Gross Profit 13.22% 34.36%
Operating Expenses $37.88M $39.50M $40.52M
YoY Change -2.52% 6.36%
Operating Profit $6.714M $3.634M $4.704M
YoY Change -22.75% 1.86%
Interest Expense -$4.682M $4.900M $3.600M
YoY Change 36.11% -12.2%
% of Operating Profit -69.73% 134.84% 76.53%
Other Income/Expense, Net $2.676M -$2.888M -$2.400M
YoY Change 20.33% -255.64%
Pretax Income -$92.00K -$4.181M -$992.0K
YoY Change 321.47% -147.06%
Income Tax $3.366M -$1.311M -$858.0K
% Of Pretax Income
Net Earnings -$3.458M -$2.870M -$134.0K
YoY Change 407.78% 2041.79% -108.56%
Net Earnings / Revenue -5.09% -4.41% -0.2%
Basic Earnings Per Share -$0.08 $0.00
Diluted Earnings Per Share -$89.54K -$0.08 $0.00
COMMON SHARES
Basic Shares Outstanding 38.86M 37.91M 37.26M
Diluted Shares Outstanding 37.91M 37.26M

Balance Sheet

Concept 2020 Q4 2020 Q3 2019 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $61.41M $64.12M
YoY Change
Cash & Equivalents $61.41M $64.12M $36.69M
Short-Term Investments
Other Short-Term Assets $51.39M $50.74M
YoY Change
Inventory $73.04M $69.40M $48.40M
Prepaid Expenses
Receivables $45.96M $46.91M $50.55M
Other Receivables $2.788M $2.520M $4.322M
Total Short-Term Assets $234.6M $233.7M $181.4M
YoY Change 25.19% 28.86% 4.26%
LONG-TERM ASSETS
Property, Plant & Equipment $33.08M $31.80M $30.43M
YoY Change 2.88% 4.49% -5.11%
Goodwill $260.1M $254.0M $183.4M
YoY Change 39.3% 38.52% -2.53%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $14.60M $14.29M $14.06M
YoY Change 2.78% 1.59% 16.09%
Total Long-Term Assets $554.8M $548.5M $411.2M
YoY Change 32.65% 33.37% 3.92%
TOTAL ASSETS
Total Short-Term Assets $234.6M $233.7M $181.4M
Total Long-Term Assets $554.8M $548.5M $411.2M
Total Assets $789.4M $782.2M $592.6M
YoY Change 30.34% 31.99% 4.02%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $9.623M $10.40M $7.455M
YoY Change -1.77% 39.49% 25.48%
Accrued Expenses $7.472M $10.34M
YoY Change 10.98%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $1.195M $1.165M $1.144M
YoY Change 2.66% 1.84% -9.64%
Total Short-Term Liabilities $60.47M $53.67M $42.19M
YoY Change 33.79% 27.2% 37.21%
LONG-TERM LIABILITIES
Long-Term Debt $290.5M $289.7M $214.8M
YoY Change 35.37% 34.87% -0.82%
Other Long-Term Liabilities $6.690M $12.84M $15.37M
YoY Change 1.66% -16.46% -20.94%
Total Long-Term Liabilities $297.2M $302.5M $230.2M
YoY Change 34.37% 31.44% -2.48%
TOTAL LIABILITIES
Total Short-Term Liabilities $60.47M $53.67M $42.19M
Total Long-Term Liabilities $297.2M $302.5M $230.2M
Total Liabilities $460.7M $456.4M $315.1M
YoY Change 43.98% 44.85% 7.58%
SHAREHOLDERS EQUITY
Retained Earnings $20.02M $23.48M $37.39M
YoY Change -45.45% -37.19% 4.6%
Common Stock $316.6M $316.8M $269.6M
YoY Change 16.32% 17.51% 4.11%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $328.7M $325.8M $277.5M
YoY Change
Total Liabilities & Shareholders Equity $789.4M $782.2M $592.6M
YoY Change 30.34% 31.99% 4.02%

Cashflow Statement

Concept 2020 Q4 2020 Q3 2019 Q3
OPERATING ACTIVITIES
Net Income -$3.458M -$2.870M -$134.0K
YoY Change 407.78% 2041.79% -108.56%
Depreciation, Depletion And Amortization $5.894M $14.82M
YoY Change
Cash From Operating Activities $5.450M $6.919M
YoY Change
INVESTING ACTIVITIES
Capital Expenditures -$2.157M -$5.171M
YoY Change
Acquisitions
YoY Change
Other Investing Activities -$189.0K -$65.61M
YoY Change
Cash From Investing Activities -$2.346M -$70.78M
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -1.682M 95.29M
YoY Change
NET CHANGE
Cash From Operating Activities 5.450M 6.919M
Cash From Investing Activities -2.346M -70.78M
Cash From Financing Activities -1.682M 95.29M
Net Change In Cash 1.422M 31.43M
YoY Change
FREE CASH FLOW
Cash From Operating Activities $5.450M $6.919M
Capital Expenditures -$2.157M -$5.171M
Free Cash Flow $7.607M $12.09M
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2020-09-30
CY2019Q4 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
CY2019Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2020Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2019 us-gaap Unrealized Gain Loss On Securities
UnrealizedGainLossOnSecurities
us-gaap Unrealized Gain Loss On Securities
UnrealizedGainLossOnSecurities
dei Document Type
DocumentType
10-Q
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
dei Entity Central Index Key
EntityCentralIndexKey
0000784199
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
1-13165
dei Entity Registrant Name
EntityRegistrantName
CRYOLIFE INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
FL
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
59-2417093
dei Entity Address Address Line1
EntityAddressAddressLine1
1655 Roberts Boulevard, NW
dei Entity Address City Or Town
EntityAddressCityOrTown
Kennesaw
dei Entity Address State Or Province
EntityAddressStateOrProvince
GA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
30144
dei City Area Code
CityAreaCode
770
dei Local Phone Number
LocalPhoneNumber
419-3355
dei Security12b Title
Security12bTitle
Common Stock, $0.01 par value
dei Trading Symbol
TradingSymbol
CRY
dei Security Exchange Name
SecurityExchangeName
NYSE
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2020Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
38857435
CY2020Q3 us-gaap Revenues
Revenues
65131000
CY2019Q3 us-gaap Revenues
Revenues
67881000
us-gaap Revenues
Revenues
185331000
us-gaap Revenues
Revenues
206525000
CY2020Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
21999000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
105402000
CY2020Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5755000
cry Interest Expense Including Reversal Of Interest
InterestExpenseIncludingReversalOfInterest
11980000
CY2019Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
22659000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
62138000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
70064000
CY2020Q3 us-gaap Gross Profit
GrossProfit
43132000
CY2019Q3 us-gaap Gross Profit
GrossProfit
45222000
us-gaap Gross Profit
GrossProfit
123193000
us-gaap Gross Profit
GrossProfit
136461000
CY2020Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
33743000
CY2019Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
34259000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
105033000
CY2019Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6259000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
17633000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
17648000
CY2020Q3 us-gaap Operating Expenses
OperatingExpenses
39498000
CY2019Q3 us-gaap Operating Expenses
OperatingExpenses
40518000
us-gaap Operating Expenses
OperatingExpenses
122666000
us-gaap Operating Expenses
OperatingExpenses
123050000
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
3634000
CY2019Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
4704000
us-gaap Operating Income Loss
OperatingIncomeLoss
527000
us-gaap Operating Income Loss
OperatingIncomeLoss
13411000
CY2020Q3 cry Interest Expense Including Reversal Of Interest
InterestExpenseIncludingReversalOfInterest
4940000
CY2019Q3 cry Interest Expense Including Reversal Of Interest
InterestExpenseIncludingReversalOfInterest
3555000
cry Interest Expense Including Reversal Of Interest
InterestExpenseIncludingReversalOfInterest
11260000
CY2020Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
13000
CY2019Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
259000
us-gaap Investment Income Interest
InvestmentIncomeInterest
181000
us-gaap Investment Income Interest
InvestmentIncomeInterest
608000
CY2020Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-2888000
CY2019Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-2400000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-5810000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-2662000
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-4181000
CY2019Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-992000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-17082000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
97000
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1311000
CY2019Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-858000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-3858000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-2304000
us-gaap Net Income Loss
NetIncomeLoss
-13224000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-2870000
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
-134000
us-gaap Net Income Loss
NetIncomeLoss
-13224000
us-gaap Net Income Loss
NetIncomeLoss
2401000
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.08
CY2019Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.35
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.06
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.08
CY2019Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.35
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.06
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
37912000
CY2019Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
37255000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
37608000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
37065000
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
37912000
CY2019Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
37255000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
37608000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
37850000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-2870000
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
-134000
us-gaap Net Income Loss
NetIncomeLoss
2401000
CY2020Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
8698000
CY2019Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-8017000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
8669000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-8803000
CY2020Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
5828000
CY2019Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-8151000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-4555000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-6402000
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
64122000
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
33766000
CY2020Q3 us-gaap Restricted Investments Current
RestrictedInvestmentsCurrent
513000
CY2019Q4 us-gaap Restricted Investments Current
RestrictedInvestmentsCurrent
528000
CY2020Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
46911000
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
52940000
CY2020Q3 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
2520000
CY2019Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
2921000
CY2020Q3 us-gaap Inventory Net
InventoryNet
69402000
CY2019Q4 us-gaap Inventory Net
InventoryNet
53071000
CY2020Q3 cry Deferred Preservation Costs
DeferredPreservationCosts
35952000
CY2019Q4 cry Deferred Preservation Costs
DeferredPreservationCosts
32551000
CY2020Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
14279000
CY2019Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
11613000
CY2020Q3 us-gaap Assets Current
AssetsCurrent
233699000
CY2019Q4 us-gaap Assets Current
AssetsCurrent
187390000
CY2020Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
31799000
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
32150000
CY2020Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
19438000
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
21994000
CY2020Q3 us-gaap Goodwill
Goodwill
253995000
CY2019Q4 us-gaap Goodwill
Goodwill
186697000
CY2020Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
185010000
CY2019Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
115415000
CY2020Q3 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
40697000
CY2019Q4 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
42319000
CY2020Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
3274000
CY2019Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
5481000
CY2020Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
14288000
CY2019Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
14208000
CY2020Q3 us-gaap Assets
Assets
782200000
CY2019Q4 us-gaap Assets
Assets
605654000
CY2020Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
10399000
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
9796000
CY2020Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
11644000
CY2019Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
12260000
CY2020Q3 cry Accrued Procurement Fees
AccruedProcurementFees
4057000
CY2019Q4 cry Accrued Procurement Fees
AccruedProcurementFees
4362000
CY2020Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
5678000
CY2019Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
5487000
CY2020Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
1165000
CY2019Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
1164000
CY2020Q3 us-gaap Taxes Payable Current
TaxesPayableCurrent
6140000
CY2019Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
2984000
CY2020Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
10344000
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
6733000
CY2020Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
4240000
CY2019Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
2409000
CY2020Q3 us-gaap Liabilities Current
LiabilitiesCurrent
53667000
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
45195000
CY2020Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
289697000
CY2019Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
214571000
CY2020Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
24813000
CY2020Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
40341000
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
39018000
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-8589000
CY2019Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
1484000
CY2020Q3 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
1484000
CY2020Q3 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
14591000
CY2019Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
14591000
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
325766000
CY2019Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
25844000
CY2020Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
15026000
CY2019Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
17918000
CY2020Q3 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
4982000
CY2019Q4 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
4434000
CY2020Q3 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
55407000
CY2020Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
12842000
CY2019Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
11996000
CY2020Q3 us-gaap Liabilities
Liabilities
456434000
CY2019Q4 us-gaap Liabilities
Liabilities
319958000
CY2020Q3 us-gaap Common Stock Value
CommonStockValue
403000
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
390000
CY2020Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
316394000
CY2019Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
271782000
CY2020Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
23480000
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
36704000
CY2020Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
80000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
285696000
CY2020Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
782200000
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
605654000
us-gaap Net Income Loss
NetIncomeLoss
-13224000
us-gaap Net Income Loss
NetIncomeLoss
2401000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
14818000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
13257000
us-gaap Share Based Compensation
ShareBasedCompensation
7432000
us-gaap Share Based Compensation
ShareBasedCompensation
6581000
cry Noncash Lease Expense
NoncashLeaseExpense
5324000
cry Noncash Lease Expense
NoncashLeaseExpense
3491000
cry Change In Fair Value Of Long Term Loan
ChangeInFairValueOfLongTermLoan
4949000
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
4916000
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
1064000
cry Noncash Interest Expense
NoncashInterestExpense
2261000
cry Noncash Interest Expense
NoncashInterestExpense
1266000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-1631000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
14767000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
59643000
us-gaap Payments To Acquire Loans Receivable
PaymentsToAcquireLoansReceivable
5000000
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
30000000
cry Proceeds From Financing Insurance Premiums
ProceedsFromFinancingInsurancePremiums
2816000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
2079000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
4519000
us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
30000000
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
3647000
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
3727000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-1328000
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-7718000
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
4496000
cry Increase Decrease In Deferred Preservation Costs And Inventories
IncreaseDecreaseInDeferredPreservationCostsAndInventories
19744000
cry Increase Decrease In Deferred Preservation Costs And Inventories
IncreaseDecreaseInDeferredPreservationCostsAndInventories
3864000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2560000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
3020000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
3230000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-1113000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
6919000
us-gaap Payments To Acquire Loans Receivable
PaymentsToAcquireLoansReceivable
15000000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
5171000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
5222000
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
968000
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
531000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-70782000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-20753000
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
100000000
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
2072000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
1768000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
2723000
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-463000
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-560000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
95290000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-836000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-1086000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1763000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
30341000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-5059000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
34294000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
42236000
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
64635000
CY2019Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
37177000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
296556000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-2870000
CY2020Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
8698000
CY2020Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
5828000
CY2020Q3 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
20000000
CY2020Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
2518000
CY2020Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
31000
CY2020Q3 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
873000
CY2020Q3 us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
40000
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
325766000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
285696000
us-gaap Net Income Loss
NetIncomeLoss
-13224000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
8669000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-4555000
us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
20000000
us-gaap Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt
AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt
16426000
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
7888000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
518000
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1561000
us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
1768000
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
325766000
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
282153000
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
-134000
CY2019Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-8017000
CY2019Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-8151000
CY2019Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
2620000
CY2019Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
53000
CY2019Q3 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
885000
CY2019Q3 us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
59000
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
277501000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
275067000
us-gaap Net Income Loss
NetIncomeLoss
2401000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-8803000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-6402000
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
7039000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
3057000
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1463000
us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
2723000
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
277501000
us-gaap Basis Of Accounting
BasisOfAccounting
<span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: bold;margin: 0;padding: 0;">1. Basis of Presentation  </span><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: bold;margin: 0;padding: 0;">Overview</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">The accompanying summary consolidated financial statements include the accounts of CryoLife, Inc. and its subsidiaries (“CryoLife,” the “Company,” “we,” or “us”). All significant intercompany accounts and transactions have been eliminated in consolidation. The accompanying Summary Consolidated Balance Sheet as of December 31, 2019 has been derived from audited financial statements. The accompanying unaudited summary consolidated financial statements as of, and for the three and nine months ended, September 30, 2020 and 2019 have been prepared in accordance with (i) accounting principles generally accepted in the U.S. for interim financial information and (ii) the instructions to Form 10-Q and Rule 10-01 of Regulation S-X of the U.S. Securities and Exchange Commission (“SEC”). Accordingly, such statements do not include all the information and disclosures that are required by accounting principles generally accepted in the U.S. for a complete presentation of financial statements. In the opinion of management, all adjustments (including those of a normal, recurring nature) considered necessary for a fair presentation have been included. Operating results for the three and nine months ended September 30, 2020 are not necessarily indicative of the results that may be expected for the year ending December 31, 2020. These summary consolidated financial statements should be read in conjunction with the consolidated financial statements and notes included in CryoLife’s Annual Report on Form 10-K for the year ended December 31, 2019 filed with the SEC on February 19, 2020.</span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: bold;margin: 0;padding: 0;">New Accounting Standards</span></p><p dir="ltr" style="background: #FFFFFF;font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-indent: 0.25in;"><span style="white-space:pre-wrap; color: #212529;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;">Recently Adopted</span></p><p dir="ltr" style="background: #FFFFFF;font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-indent: 0.25in;"><span style="white-space:pre-wrap; color: #212529;font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="background: #FFFFFF;font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-indent: 0.25in;"><span style="white-space:pre-wrap; color: #212529;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">In June 2016, the</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> Financial Accounting Standards Board (“FASB”) issued ASC Update No. 2016-13, </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;">Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">(“ASU 2016-13”)</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;">.</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> The purpose of Update No. 2016-13 is to replace the current incurred loss impairment methodology for financial assets measured at amortized cost with a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information, including forecasted information, to develop credit loss estimates. Update No. 2016-13 is effective for annual periods beginning after December 15, 2019. The Company adopted this new guidance on January 1, 2020. The adoption of ASU 2016-13 did not result in a material effect on the Company’s financial condition, results of operations, or cash flows.</span></p><p dir="ltr" style="background: #FFFFFF;font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;">Not Yet Effective</span></p><p dir="ltr" style="background: #FFFFFF;font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-indent: 0.25in;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><p dir="ltr" style="background: #FFFFFF;font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: 0;margin-left: 0;margin-right: 0;margin-top: 0;text-indent: 0.25in;"><span style="white-space:pre-wrap; color: #212529;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">In August 2020, the FASB issued </span><span id="keyword" style="text-decoration: none;"/><span style="white-space:pre-wrap; color: #212529;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">ASC Update No. 2020-06, </span><span style="white-space:pre-wrap; color: #212529;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: normal;margin: 0;padding: 0;">Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity’s Own Equity</span><span style="white-space:pre-wrap; color: #212529;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> (“ASU 2020-06”) The update simplifies the accounting for convertible debt instruments and convertible preferred stock by reducing the number of accounting models and the number of embedded conversion features that could be recognized separately from the primary contract. ASU 2020-06 also enhances transparency and improves disclosures for convertible instruments and earnings per share guidance. ASU 2020-06 is effective for annual reporting periods beginning after December 15, 2021, including interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020. This update permits the use of either the modified retrospective or fully retrospective method of transition. </span><span style="white-space:pre-wrap; color: #212529;font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">We are in the process of evaluating the effect that the adoption of this standard will have on our financial position and results of operations.  </span></p>
CY2020Q3 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
55400000
CY2020Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
55407000
CY2020Q3 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
55407000
CY2020Q3 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
12405000
CY2019Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
2358000
CY2019Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
358000
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Purchases
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases
5000000
cry Discounted Value Of Contingent Consideration At Acquisition
DiscountedValueOfContingentConsiderationAtAcquisition
-55407000
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements
4949000
CY2020Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
409000
CY2020Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
55407000
CY2020Q3 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
11996000
CY2020Q3 cry Restricted Cash Fair Value Disclosure
RestrictedCashFairValueDisclosure
11996000
CY2019Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
2000000
CY2019Q4 cry Restricted Cash Fair Value Disclosure
RestrictedCashFairValueDisclosure
2000000
us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
0
CY2019Q3 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
0
us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
0
CY2020Q3 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
0
CY2020Q3 us-gaap Inventory Raw Materials And Supplies Net Of Reserves
InventoryRawMaterialsAndSuppliesNetOfReserves
30875000
CY2019Q4 us-gaap Inventory Raw Materials And Supplies Net Of Reserves
InventoryRawMaterialsAndSuppliesNetOfReserves
21180000
CY2020Q3 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
7461000
CY2019Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
5127000
CY2020Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
31066000
CY2019Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
26764000
CY2020Q3 us-gaap Inventory Net
InventoryNet
69402000
CY2019Q4 cry Deferred Preservation Costs
DeferredPreservationCosts
32551000
CY2020Q3 us-gaap Other Inventory Materials Supplies And Merchandise Under Consignment
OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment
12800000
CY2019Q4 us-gaap Other Inventory Materials Supplies And Merchandise Under Consignment
OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment
12000000.0
CY2019Q4 us-gaap Inventory Net
InventoryNet
53071000
CY2020Q3 cry Deferred Preservation Costs
DeferredPreservationCosts
35952000
CY2020Q3 us-gaap Goodwill
Goodwill
253995000
CY2019Q4 us-gaap Goodwill
Goodwill
186697000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
9430000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
7796000
CY2019Q4 us-gaap Goodwill
Goodwill
186697000
us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
62724000
us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
4574000
CY2020Q3 us-gaap Goodwill
Goodwill
253995000
CY2020Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
3397000
CY2019Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2660000
CY2020Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
4127000
CY2020Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
16506000
CY2020Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
15959000
CY2020Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
15486000
CY2020Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
15160000
CY2020Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
13079000
CY2020Q3 cry Finite Lived Intangible Assets Amortization Expense Estimate
FiniteLivedIntangibleAssetsAmortizationExpenseEstimate
80317000
CY2020Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.31
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.23
CY2019Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.87
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
23.75
CY2020Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
5678000
CY2019Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
5487000
CY2020Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
15026000
CY2020Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
2700000
CY2020Q3 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
21500000
CY2019Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
3200000
CY2019Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
20400000
CY2020Q1 cry Cares Act Income Tax Effect
CaresActIncomeTaxEffect
1300000
cry Number Of Subleases
NumberOfSubleases
2
CY2020Q3 cry Property Plant And Equipment And Operating Lease Right Of Use Asset Before Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
28365000
CY2019Q4 cry Property Plant And Equipment And Operating Lease Right Of Use Asset Before Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
27007000
CY2020Q3 cry Property Plant And Equipment And Operating Lease Right Of Use Asset Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
8927000
CY2019Q4 cry Property Plant And Equipment And Operating Lease Right Of Use Asset Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
5013000
CY2020Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
19438000
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
21994000
CY2019Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
17918000
CY2020Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
20704000
CY2019Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
23405000
CY2020Q3 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
7369000
CY2019Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
7161000
CY2020Q3 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
1743000
CY2019Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
1279000
CY2020Q3 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
5626000
CY2019Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
5882000
CY2020Q3 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
595000
CY2019Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
597000
CY2020Q3 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
5206000
CY2019Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
5415000
CY2020Q3 us-gaap Finance Lease Liability
FinanceLeaseLiability
5801000
CY2019Q4 us-gaap Finance Lease Liability
FinanceLeaseLiability
6012000
CY2020Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y2M12D
CY2019Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y6M
CY2020Q3 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P10Y
CY2019Q4 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P10Y7M6D
CY2020Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.052
CY2019Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.054
CY2020Q3 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.020
CY2019Q4 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.020
CY2020Q3 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
164000
CY2020Q3 us-gaap Lease Cost
LeaseCost
1774000
CY2019Q3 us-gaap Lease Cost
LeaseCost
1708000
us-gaap Lease Cost
LeaseCost
5221000
us-gaap Lease Cost
LeaseCost
4892000
us-gaap Sublease Income
SubleaseIncome
679000
CY2019Q3 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
188000
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
487000
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
608000
CY2020Q3 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
30000
CY2019Q3 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
30000
us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
89000
us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
93000
CY2020Q3 cry Finance Lease Cost
FinanceLeaseCost
194000
CY2019Q3 cry Finance Lease Cost
FinanceLeaseCost
218000
cry Finance Lease Cost
FinanceLeaseCost
576000
cry Finance Lease Cost
FinanceLeaseCost
701000
CY2020Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
1806000
CY2019Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
1717000
us-gaap Operating Lease Cost
OperatingLeaseCost
5324000
us-gaap Operating Lease Cost
OperatingLeaseCost
4870000
CY2020Q3 us-gaap Sublease Income
SubleaseIncome
226000
CY2019Q3 us-gaap Sublease Income
SubleaseIncome
227000
us-gaap Sublease Income
SubleaseIncome
679000
us-gaap Operating Lease Payments
OperatingLeasePayments
5438000
us-gaap Operating Lease Payments
OperatingLeasePayments
5004000
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
465000
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
561000
us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
92000
us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
91000
CY2020Q3 us-gaap Finance Lease Liability Payments Remainder Of Fiscal Year
FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear
178000
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
1435000
CY2020Q3 cry Operating Leases Future Minimum Payments Due Future Minimum Sublease Rentals Remainder Of Fiscal Year
OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsRemainderOfFiscalYear
226000
CY2020Q3 us-gaap Finance Lease Liability Payments Due Next Twelve Months
FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
695000
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
6823000
CY2020Q3 cry Operating Leases Future Minimum Payments Due Future Minimum Sublease Rentals Due In Next Twelve Months
OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsDueInNextTwelveMonths
905000
CY2020Q3 us-gaap Finance Lease Liability Payments Due Year Two
FinanceLeaseLiabilityPaymentsDueYearTwo
639000
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
4340000
CY2020Q3 cry Operating Leases Future Minimum Payments Due Future Minimum Sublease Rentals Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentalsDueInTwoYears
306000
CY2020Q3 us-gaap Finance Lease Liability Payments Due Year Three
FinanceLeaseLiabilityPaymentsDueYearThree
638000
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
2877000
CY2020Q3 us-gaap Finance Lease Liability Payments Due Year Four
FinanceLeaseLiabilityPaymentsDueYearFour
636000
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
2706000
CY2020Q3 us-gaap Finance Lease Liability Payments Due After Year Five
FinanceLeaseLiabilityPaymentsDueAfterYearFive
3612000
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
5283000
CY2020Q3 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
6398000
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
23464000
CY2020Q3 us-gaap Operating Leases Future Minimum Payments Due Future Minimum Sublease Rentals
OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentals
1437000
CY2020Q3 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
597000
CY2020Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
2760000
CY2020Q3 us-gaap Finance Lease Liability
FinanceLeaseLiability
5801000
CY2020Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
20704000
CY2020Q3 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
595000
CY2020Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
5678000
CY2020Q3 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
5206000
CY2020Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
15026000
CY2020Q3 cry Debt Instrument Debt Default Interest Rate
DebtInstrumentDebtDefaultInterestRate
0.0200
CY2020Q3 us-gaap Line Of Credit Facility Interest Rate At Period End
LineOfCreditFacilityInterestRateAtPeriodEnd
0.0425
us-gaap Line Of Credit Facility Commitment Fee Percentage
LineOfCreditFacilityCommitmentFeePercentage
0.0050
CY2020Q3 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
299848000
CY2019Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
223176000
CY2020Q3 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
8986000
CY2019Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
7441000
CY2020Q3 us-gaap Long Term Debt
LongTermDebt
290862000
CY2019Q4 us-gaap Long Term Debt
LongTermDebt
215735000
CY2020Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
1165000
CY2019Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
1164000
CY2020Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
289697000
CY2019Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
214571000
CY2020Q3 us-gaap Interest Expense
InterestExpense
4900000
us-gaap Interest Expense
InterestExpense
12000000.0
CY2019Q3 us-gaap Interest Expense
InterestExpense
3600000
us-gaap Interest Expense
InterestExpense
11300000
CY2020Q3 us-gaap Loss Contingency Accrual Product Liability Gross
LossContingencyAccrualProductLiabilityGross
2000000.0
CY2019Q4 us-gaap Loss Contingency Accrual Product Liability Gross
LossContingencyAccrualProductLiabilityGross
1900000
CY2020Q3 us-gaap Reinsurance Receivables Incurred But Not Reported Claims
ReinsuranceReceivablesIncurredButNotReportedClaims
1000000.0
CY2019Q4 us-gaap Reinsurance Receivables Incurred But Not Reported Claims
ReinsuranceReceivablesIncurredButNotReportedClaims
935000
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
7888000
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
7039000
CY2020Q3 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
160000
us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
456000
CY2019Q3 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
158000
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
65131000
CY2019Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
67881000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
185331000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
206525000
CY2019 cry Percentage Of Target Number Of Shares Of Common Stock Granted As Performance Stock Units
PercentageOfTargetNumberOfSharesOfCommonStockGrantedAsPerformanceStockUnits
0.83
CY2020Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
2518000
CY2019Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
2620000
us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
458000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-2870000
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
-134000
us-gaap Net Income Loss
NetIncomeLoss
-13224000
us-gaap Net Income Loss
NetIncomeLoss
2401000
CY2020Q3 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
-20000
CY2019Q3 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
-1000
us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
-93000
us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
17000
CY2020Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-2850000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
37065000
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.08
CY2019Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.35
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.06
CY2019Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-133000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-13131000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
2384000
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
37912000
CY2019Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
37255000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
37608000
CY2019Q3 us-gaap Revenues
Revenues
67881000
CY2020Q3 us-gaap Revenues
Revenues
65131000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-2870000
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
-134000
us-gaap Net Income Loss
NetIncomeLoss
-13224000
us-gaap Net Income Loss
NetIncomeLoss
2401000
CY2020Q3 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Diluted
UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted
-20000
CY2019Q3 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Diluted
UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted
-1000
us-gaap Undistributed Earnings Loss Allocated To Participating Securities Diluted
UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted
-93000
us-gaap Undistributed Earnings Loss Allocated To Participating Securities Diluted
UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted
16000
CY2020Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-2850000
CY2019Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-133000
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-13131000
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
2385000
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
37912000
CY2019Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
37255000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
37608000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
37065000
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
785000
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
37912000
CY2019Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
37255000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
37608000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
37850000
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.08
CY2019Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.35
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.06
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
123000
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2
CY2019Q3 us-gaap Revenues
Revenues
67881000
us-gaap Revenues
Revenues
185331000
us-gaap Revenues
Revenues
206525000
CY2020Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
21999000
CY2019Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
22659000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
62138000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
70064000
CY2020Q3 us-gaap Gross Profit
GrossProfit
43132000
CY2019Q3 us-gaap Gross Profit
GrossProfit
45222000
us-gaap Gross Profit
GrossProfit
123193000
us-gaap Gross Profit
GrossProfit
136461000
CY2020Q3 us-gaap Revenues
Revenues
65131000
us-gaap Revenues
Revenues
185331000
us-gaap Revenues
Revenues
206525000

Files In Submission

Name View Source Status
0000784199-20-000208-index-headers.html Edgar Link pending
0000784199-20-000208-index.html Edgar Link pending
0000784199-20-000208.txt Edgar Link pending
0000784199-20-000208-xbrl.zip Edgar Link pending
cry-20200930.xsd Edgar Link pending
cry-20200930x10q.htm Edgar Link pending
cry-20200930x10q_htm.xml Edgar Link completed
cry-20200930xex31_1.htm Edgar Link pending
cry-20200930xex31_2.htm Edgar Link pending
cry-20200930xex32.htm Edgar Link pending
cry-20200930_cal.xml Edgar Link unprocessable
cry-20200930_def.xml Edgar Link unprocessable
cry-20200930_lab.xml Edgar Link unprocessable
cry-20200930_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending